Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CI(R)CA : Coumadin Interaction With Rofecoxib, Celecoxib and Acetaminophen. A Prospective Double-blind, Placebo Controlled Study.

NCT01762891 is registered in ClinicalTrials.gov with Hospital Universitario Pedro Ernesto as lead sponsor.

NCT NCT01762891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01762891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CI(R)CA : Coumadin Interaction With Rofecoxib, Celecoxib and Acetaminophen. A Prospective Double-blind, Placebo Controlled Study.
Lead sponsor
Hospital Universitario Pedro Ernesto
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2003
Completion date
September 30, 2009
Enrollment
22 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

antiphospholipid antibody syndrome